Clinical Trials Browser

Phase 1 × navicixizumab × Other solid neoplasm × Clear all

NCT02298387 2020-08-11

A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor Malignancies